Lana Medical Co. (9587.SR)
SAR 45.9
(0.11%)
SAR 45.9
(0.11%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 1.42 Million | 5.45 Million | -4.94 Million | 387.58 Thousand | 2.44 Million |
| Net Income | 3 Million | 5.49 Million | 6.59 Million | 4.19 Million | - |
| Depreciation & Amortization | 1.84 Million | 1.52 Million | 1.07 Million | 891.39 Thousand | - |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | -8.22 Million | -3.9 Million | -13.96 Million | -5.01 Million | - |
| Other non-cash items | 20.91 Million | 9.79 Million | 18.12 Million | 8.43 Million | 2.44 Million |
| Investing Cash Flow | -4.04 Million | -5.09 Million | -7.09 Million | -2.93 Million | -2.22 Million |
| Investments in PPE | -4.22 Million | -5.09 Million | -7.21 Million | -3 Million | - |
| Acquisitions | 177 Thousand | - | 8000.00 | 52 Thousand | - |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | -4.04 Million | - | 112.05 Thousand | 18.67 Thousand | -2.22 Million |
| Financing Cash Flow | 18.07 Million | -567.66 Thousand | 11.98 Million | 3.54 Million | 628.79 Thousand |
| Debt repayment | -1.07 Million | -187.96 Thousand | -106.41 Thousand | -2.02 Million | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 17.51 Million | - | 13 Million | 2.04 Million | - |
| Other Financing Activities | 18.07 Million | - | 13 Thousand | - | 628.79 Thousand |
| Accounts receivables | -12.22 Million | -4.34 Million | -15.72 Million | -5.64 Million | - |
| Accounts payables | 559.03 Thousand | -38.49 Thousand | 403.17 Thousand | -77.5 Thousand | - |
| Inventory | -770.81 Thousand | -16.72 Thousand | 704.21 Thousand | -611.06 Thousand | - |
| Other working capital | 4.21 Million | 495.57 Thousand | 651.47 Thousand | 1.31 Million | - |
| Cash at beginning of period | 3.3 Million | 3.51 Million | 3.57 Million | 2.58 Million | 1.73 Million |
| Cash at end of period | 18.75 Million | 3.3 Million | 3.51 Million | 3.57 Million | 2.58 Million |
| Capital Expenditure | -4.22 Million | -5.09 Million | -7.21 Million | -3 Million | - |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | 15.45 Million | -212.1 Thousand | -62.94 Thousand | 997.76 Thousand | 849.11 Thousand |
| Free Cash Flow | -2.79 Million | 355.56 Thousand | -12.16 Million | -2.61 Million | 2.44 Million |
| Breakdown | 2024 Q2 | 2023 FY | 2022 FY | 2021 FY | 2020 FY |
|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - |
| Net Income | 3.22 Million | 3 Million | 5.49 Million | 6.59 Million | 4.19 Million |
| Depreciation & Amortization | 1.37 Million | 1.84 Million | 1.52 Million | 1.07 Million | 891.39 Thousand |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | -10.41 Million | -8.22 Million | -3.9 Million | -13.96 Million | -5.01 Million |
| Other non-cash items | 1.82 Million | 20.91 Million | 9.79 Million | 18.12 Million | 8.43 Million |
| Investing Cash Flow | -5.32 Million | -4.04 Million | -5.09 Million | -7.09 Million | -2.93 Million |
| Investments in PPE | -1.45 Million | -4.22 Million | -5.09 Million | -7.21 Million | -3 Million |
| Acquisitions | -3.86 Million | 177 Thousand | - | 8000.00 | 52 Thousand |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | - | - | - | 112.05 Thousand | 18.67 Thousand |
| Financing Cash Flow | -1.23 Million | 18.07 Million | -567.66 Thousand | 11.98 Million | 3.54 Million |
| Debt repayment | -897.54 Thousand | -1.07 Million | -187.96 Thousand | -106.41 Thousand | -2.02 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | 17.51 Million | - | 13 Million | 2.04 Million |
| Other Financing Activities | -340 Thousand | - | - | 13 Thousand | - |
| Accounts receivables | -9.65 Million | -12.22 Million | -4.34 Million | -15.72 Million | -5.64 Million |
| Accounts payables | 752.34 Thousand | 559.03 Thousand | -38.49 Thousand | 403.17 Thousand | -77.5 Thousand |
| Inventory | -1.68 Million | -770.81 Thousand | -16.72 Thousand | 704.21 Thousand | -611.06 Thousand |
| Other working capital | 177.67 Thousand | 4.21 Million | 495.57 Thousand | 651.47 Thousand | 1.31 Million |
| Cash at beginning of period | 18.75 Million | 3.3 Million | 3.51 Million | 3.57 Million | 2.58 Million |
| Cash at end of period | 8.19 Million | 18.75 Million | 3.3 Million | 3.51 Million | 3.57 Million |
| Capital Expenditure | -1.45 Million | -4.22 Million | -5.09 Million | -7.21 Million | -3 Million |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | -10.55 Million | 15.45 Million | -212.1 Thousand | -62.94 Thousand | 997.76 Thousand |
| Free Cash Flow | -5.45 Million | -2.79 Million | 355.56 Thousand | -12.16 Million | -2.61 Million |
CNTX
002519
7991
0J5I
NIITLTD
000887